Innovative Wound Care
Delivering wound care technology that works seamlessly across the care continuum and that can transform patients’ lives.
We deliver advanced solutions to aid wound healing—even in chronic, non-healing wounds. Our innovative online platform makes it easier for healthcare professionals to manage wounds.
Our Mission
Chronic wounds affect millions worldwide. Our mission is to transform the lives of patients suffering from hard-to-heal wounds through our innovative wound care brand, NATROX®.
Passion for medicine, compassion for patients, respect among employees, and commitment to delight all our internal and external customers drives our success and enables us to restore hope to those who need it most.
Chronic Wounds:
The silent epidemic
Chronic wounds, or wounds that are slow to heal, affect millions of people worldwide, representing a burden for healthcare systems, society, and patients. It’s time to fight the silent epidemic.
Did you know 18% of global wounds are considered chronic?1 Costs to care for these wounds account for 60% of total wound care costs. But there are hidden costs, too.
Globally chronic wounds result in:
+0%
more GP visits2
+0%
more hospital admissions2
+0%
more nurse practitioner visits2
Easy to Use
Device
Empowers
Patients
NATROX® O2 stimulates healing in previously non-healing wounds. Designed with simple elegance, this supplemental topical oxygen therapy offers convenience without compromise.
Using the natural properties of oxygen to heal.
Intuitive
Online
Platform
Supports
Clinicians
NATROX IQ® is an advanced digital platform designed to help clinicians with the management of their caseload. Designed specifically for wound care, up-to-date data can be captured and accessed across multiple care teams and settings.
Consistent
wound
measurements
Automated
data
capture
Remote
wound
assessments
Take the pain out of documentation.
Get in Touch
Complete this form to hear from our team. By using this form, you agree with our data storage and handling policy.
Reference List
References
[1] Bionap, 2013. Seeking alpha [online] Available at: https://bit.ly/SeekingAlpha2014 [Accessed 16 Jan 2020]
[2] Guest, JF, et al, 2015. Health economic burden that wounds impose on the National Health Service in the UK: BMJ Open 2015:5:E009283. DOI:10.1136/BMJopen-2015-009283
[3] Jones, N.C., G; Ivins, N.M.; Harding, K.G et al. (2017) The role of topical oxygen therapy in the treatment of diabetic foot ulceration. Poster in Wounds UK Harrogate, UK.
[4] Serena TE, Bullock NM, Cole W et al. Topical oxygen therapy in the treatment of diabetic foot ulcers: a multicentre, open, randomised controlled trial. J Wound Care 2021; 30: Suppl.5 S7-14